Search

Your search keyword '"BIFFI, MAURO"' showing total 27 results
Start Over Author "BIFFI, MAURO" Journal journal of cardiovascular medicine
27 results on '"BIFFI, MAURO"'

1. SCN5A mutation is associated with a higher Shanghai Score in patients with type 1 Brugada ECG pattern

Author

Tonelli, Laura, Balla, Cristina, Farnè, Marianna, Margutti, Alice, Maniscalchi, Eugenia Tiziana, De Feo, Gaetano, Di Domenico, Assunta, De Raffele, Martina, Percesepe, Antonio, Uliana, Vera, Barili, Valeria, Serra, Walter, Sassone, Biagio, Virzì, Santo, De Maria, Elia, Parmeggiani, Giulia, Assenza, Gabriele Egidy, Biagini, Elena, Parisi, Vanda, Biffi, Mauro, Carinci, Valeria, Perugini, Enrica, Imbrici, Paola, Ferlini, Alessandra, Bertini, Matteo, Selvatici, Rita, and Gualandi, Francesca

Published
2023
Full Text
View/download PDF

8. Incremental value of atrial sensing in the diagnosis of ICD recordings: findings from the THINGS registry

Author

Carinci, Valeria, primary, Ziacchi, Matteo, additional, Iori, Matteo, additional, De Maria, Elia, additional, Bolognesi, Maria Giulia, additional, Zardini, Marco, additional, Calvi, Valeria, additional, Allocca, Giuseppe, additional, Ammendola, Ernesto, additional, Boggian, Giulio, additional, Saporito, Davide, additional, Giorgi, Davide, additional, Statuto, Giovanni, additional, Giacopelli, Daniele, additional, Grassini, Diego, additional, and Biffi, Mauro, additional

Published
2022
Full Text
View/download PDF

10. Manufacturer change and risk of system-related complications after implantable cardioverter defibrillator replacement: physicians’ survey and data from the Detect Long-term Complications After Implantable Cardioverter Defibrillator Replacement Registry

Author

Biffi, Mauro, Menardi, Endrj, Narducci, Maria L., Ammendola, Ernesto, Messano, Loredana, Giofrè, Fabrizio, Baiocchi, Claudia, Saporito, Davide, Lissoni, Fabio, Bertini, Matteo, Pierantozzi, Attilio, Zingarini, Gianluca, Malacrida, Maurizio, and Ziacchi, Matteo

Published
2017
Full Text
View/download PDF

11. Personalizing configuration for atrial fibrillation external electrical cardioversion to improve first shock efficacy

Author

Massaro, Giulia, primary, Spagni, Stefano, additional, Martignani, Cristian, additional, Bettazzoni, Luca, additional, Spadotto, Alberto, additional, Ziacchi, Matteo, additional, Biffi, Mauro, additional, Galiè, Nazzareno, additional, Boriani, Giuseppe, additional, Frisoni, Jessica, additional, and Diemberger, Igor, additional

Published
2022
Full Text
View/download PDF

13. Determinants of worse prognosis in patients with cardiac resynchronization therapy defibrillators. Are ventricular arrhythmias an adjunctive risk factor?

Author

Landolina, Maurizio, primary, Boriani, Giuseppe, additional, Biffi, Mauro, additional, Cattafi, Giuseppe, additional, Capucci, Alessandro, additional, Dello Russo, Antonio, additional, Facchin, Domenico, additional, Rordorf, Roberto, additional, Sagone, Antonio, additional, Del Greco, Maurizio, additional, Morani, Giovanni, additional, Nicolis, Daniele, additional, Meloni, Sarah, additional, Grammatico, Andrea, additional, and Gasparini, Maurizio, additional

Published
2021
Full Text
View/download PDF

15. Clinically oriented device programming in bradycardia patients

Author

Palmisano, Pietro, primary, Ziacchi, Matteo, additional, Biffi, Mauro, additional, Ricci, Renato P., additional, Landolina, Maurizio, additional, Zoni-Berisso, Massimo, additional, Occhetta, Eraldo, additional, Maglia, Giampiero, additional, Botto, Gianluca, additional, Padeletti, Luigi, additional, and Boriani, Giuseppe, additional

Published
2018
Full Text
View/download PDF

16. Clinically oriented device programming in bradycardia patients

Author

Ziacchi, Matteo, primary, Palmisano, Pietro, additional, Biffi, Mauro, additional, Ricci, Renato P., additional, Landolina, Maurizio, additional, Zoni-Berisso, Massimo, additional, Occhetta, Eraldo, additional, Maglia, Giampiero, additional, Botto, Gianluca, additional, Padeletti, Luigi, additional, and Boriani, Giuseppe, additional

Published
2018
Full Text
View/download PDF

17. BLOCK HF

Author

Boriani, Giuseppe, primary, Ziacchi, Matteo, additional, Diemberger, Igor, additional, Biffi, Mauro, additional, Martignani, Cristian, additional, and Leyva, Francisco, additional

Published
2016
Full Text
View/download PDF

20. Non-valvular atrial fibrillation

Author

Boriani, Giuseppe, primary, Cimaglia, Paolo, additional, Fantecchi, Elisa, additional, Mantovani, Valentina, additional, Ziacchi, Matteo, additional, Valzania, Cinzia, additional, Martignani, Cristian, additional, Biffi, Mauro, additional, and Diemberger, Igor, additional

Published
2015
Full Text
View/download PDF

21. Prevention of infections in cardiovascular implantable electronic devices beyond the antibiotic agent

Author

De Maria, Elia, primary, Diemberger, Igor, additional, Vassallo, Pier L., additional, Pastore, Monica, additional, Giannotti, Federica, additional, Ronconi, Cinzia, additional, Romandini, Andrea, additional, Biffi, Mauro, additional, Martignani, Cristian, additional, Ziacchi, Matteo, additional, Bonfatti, Federica, additional, Tumietto, Fabio, additional, Viale, Pierluigi, additional, and Boriani, Giuseppe, additional

Published
2014
Full Text
View/download PDF

22. Cardiac resynchronization therapy

Author

Boriani, Giuseppe, primary, Ziacchi, Matteo, additional, Diemberger, Igor, additional, Valzania, Cinzia, additional, Biffi, Mauro, additional, and Martignani, Cristian, additional

Published
2014
Full Text
View/download PDF

26. Non-valvular atrial fibrillation

Author

Matteo Ziacchi, Igor Diemberger, Elisa Fantecchi, Paolo Cimaglia, Mauro Biffi, Giuseppe Boriani, Cristian Martignani, Cinzia Valzania, Valentina Mantovani, Boriani, Giuseppe, Cimaglia, Paolo, Fantecchi, Elisa, Mantovani, Valentina, Ziacchi, Matteo, Valzania, Cinzia, Martignani, Cristian, Biffi, Mauro, and Diemberger, Igor

Subjects
Oral, Male, medicine.medical_specialty, Heart Valve Diseases, MEDLINE, Non valvular atrial fibrillation, Administration, Oral, Trial, Valvular prosthesis, Terminology as Topic, Internal medicine, Atrial Fibrillation, 80 and over, medicine, Humans, Anticoagulants, Atrial fibrillation, Trials, Valvular heart disease, Aged, Aged, 80 and over, Female, Middle Aged, Randomized Controlled Trials as Topic, Patient Selection, Cardiology and Cardiovascular Medicine, cardiovascular diseases, Potential impact, business.industry, valvular heart disease, Anticoagulant, General Medicine, equipment and supplies, medicine.disease, Heart Valve Disease, Administration, cardiovascular system, Cardiology, Observational study, business, Valvular prosthesi, Human
Abstract

Aims: To evaluate the potential impact of the different definitions of non-valvular atrial fibrillation reported in the literature and to analyse the possible implications for eligibility for novel oral anticoagulants (NOACs) in clinical practice. Methods: We derived the definitions of 'non-valvular atrial fibrillation' from the exclusion criteria of the trials on NOACs, and then assessed the number and percentage of patients fulfilling the various definitions in a cohort of 500 consecutive atrial fibrillation patients, undergoing clinical and echocardiographic evaluation in our cardiology department, as either in-patients or out-patients. Results: Among the 500 atrial fibrillation patients (mean age 71.27±12.6 years), with permanent atrial fibrillation in 45.2% of the cases, hypertension was very common, either as the main diagnosis or as an associated disease. Valvular heart disease as the main diagnosis (including valvular prosthesis) accounted for 22.8% of the cases. At the echocardiographic evaluation, valvular alterations were very common, especially mitral regurgitation (present, with a variable degree of severity in 63.6% of the cases). Application of the RE-LY exclusion criteria with regard to valvular disease resulted in 116 (23.2%) patients of our cohort classified as valvular atrial fibrillation. This percentage was reduced to 12.2 and 8.8% if ROCKET-AF and ARISTOTLE/ENGAGE-AF criteria, respectively, were applied. Conclusions: Non-valvular atrial fibrillation is a common clinical entity, but without a unified definition in the literature. The impact in daily practice of the different definitions adopted in trials is noteworthy, since in one patient out of seven, the eligibility for NOACs can be questioned, simply as a consequence of adopting a more or less restrictive definition.

Published
2015
Full Text
View/download PDF

27. Cardiac resynchronization therapy

Author

Giuseppe, Boriani, Elena, Berti, Laura Maria Beatrice, Belotti, Mauro, Biffi, Angelo, Carboni, Alberto, Bandini, Edoardo, Casali, Corrado, Tomasi, Tiziano, Toselli, Paolo, Baraldi, Nicola, Bottoni, Gaetano, Barbato, Biagio, Sassone, R, Grilli, Boriani, Giuseppe, Berti, Elena, Belotti, Laura Maria Beatrice, Biffi, Mauro, Carboni, Angelo, Bandini, Alberto, Casali, Edoardo, Tomasi, Corrado, Toselli, Tiziano, Baraldi, Paolo, Bottoni, Nicola, Barbato, Gaetano, and Sassone, Biagio

Subjects
Registrie, Male, Time Factors, genetic structures, medicine.medical_treatment, Health Services Accessibility, Cardiac Resynchronization Therapy, Epidemiology, Prevalence, Prospective Studies, Registries, Practice Patterns, Physicians', Prospective cohort study, education.field_of_study, cardiac resynchronization therapy, defibrillators, epidemiology, heart failure, hospitalizations, Aged, Cardiac Resynchronization Therapy Devices, Defibrillators, Implantable, Electric Countershock, Female, Healthcare Disparities, Heart Failure, Hospitalization, Humans, Italy, Prosthesis Design, Treatment Outcome, Cardiology and Cardiovascular Medicine, General Medicine, Healthcare Disparitie, Cardiology, Physician's Practice Pattern, Human, medicine.medical_specialty, Time Factor, Defibrillation, Population, Cardiac resynchronization therapy, Cardiac Resynchronization Therapy Device, defibrillator, Internal medicine, medicine, education, business.industry, medicine.disease, Prospective Studie, Heart failure, Emergency medicine, Implant, business
Abstract

BACKGROUND: Consensus guidelines define indications for cardiac resynchronization therapy (CRT), but the variability in implant rates in 'real world' clinical practice, as well as the relationship with the epidemiology of heart failure are not defined. METHODS AND RESULTS: In Emilia-Romagna, an Italian region with around 4.4 million inhabitants, a registry was instituted to collect data on implanted devices for CRT, with (CRT-D) or without defibrillation (CRT-P) capabilities. Data from all consecutive patients resident in this region who underwent a first implant of a CRT device in years 2006-2010 were collected and standardized (considering each of the nine provinces of the region). The number of CRT implants increased progressively, with a 71% increase in 2010 compared to 2006. Between 84 and 90% of implants were with CRT-D devices. The variability in standardized implant rates among the provinces was substantial and the ratio between the provinces with the highest and the lowest implant rates was always greater than 2. Considering prevalent cases of heart failure in the period 2006-2010, the proportion of patients implanted with CRT per year ranged between 0.23 and 0.30%. CONCLUSIONS: The application in 'real world' clinical practice of CRT in heart failure is quite heterogeneous, with substantial variability even among areas belonging to the same region, with the need to make the access to this treatment more equitable. Despite the increased use of CRT, its overall rate of adoption is low, if a population of prevalent heart failure patients is selected on the basis of administrative data on hospitalizations.

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results